How Volatility Is Impacting the Biotech IPO Market

The video discusses the decline in biotech stock prices, with the NASDAQ Biotech index falling 26% due to the sell-off of riskier assets. This has affected the IPO market, making it difficult for biotech companies to raise cash. The number of biotech IPOs has decreased significantly compared to the previous year, highlighting the volatility in the market.

What has been the trend in stock prices for biotech companies over the past year?

What percentage has the NASDAQ Biotech index fallen?

What does the current state of the IPO market for biotech companies indicate?

What factors have contributed to the difficulty biotech companies face in raising cash?

How many biotech IPOs occurred this past quarter compared to last year?